The Victorian Cancer Biobank (VCB) has made a significant impact in the field of cancer research and has recently been nominated as a finalist in the Melbourne Awards for Knowledge and Innovation. This recognition celebrates VCB’s extensive contributions to cancer research and biotechnological advancements.
The VCB, a consortium between Cancer Council Victoria and several major health precincts in Melbourne, has been instrumental in cancer research since 2006. Its role includes the ethical collection and provision of human bio-specimens, facilitating numerous research projects.
The key to VCB’s success is the contributions of thousands of Victorians who have donated blood and tissue samples, an aspect highlighted by VCB General Manager Dr. Wayne Ng. He emphasizes, “People are the true power behind biobanking.”
The VCB’s impact is evident in its support for over 300 cancer research projects and the availability of 450,000 samples for global research. An example of VCB’s significant collaborations is with Rhythm Biosciences in developing ColoSTAT®, a blood test for early detection of colorectal cancer or bowel cancer, which has gained approval in several countries.
The recognition at the Melbourne Awards underscores the VCB’s role in positioning Melbourne as a leader in global cancer research. Statements from Cancer Council Victoria CEO Todd Harper AM and Victorian Minister for Medical Research The Hon. Ben Carroll reiterate the VCB’s vital contributions to medical research.
Carroll remarks, “The recognition of the Victorian Cancer Biobank at the Melbourne Awards on Knowledge and Innovation has further cemented our place on the global stage.”
Read more here.
